Integra LifeSciences
IART
258 hedge funds and large institutions have $3.2B invested in Integra LifeSciences in 2020 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 115 increasing their positions, 67 reducing their positions, and 58 closing their positions.
1,566% more call options, than puts
Call options by funds: $3.98M | Put options by funds: $239K
72% more repeat investments, than reductions
Existing positions increased: 115 | Existing positions reduced: 67
2.62% more ownership
Funds ownership: 82.3% → 84.92% (+2.6%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
8% less funds holding
Funds holding: 279 → 258 (-21)
22% less capital invested
Capital invested by funds: $4.12B → $3.2B (-$914M)
33% less first-time investments, than exits
New positions opened: 39 | Existing positions closed: 58
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$33.9M |
| 2 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
+$30.4M |
| 3 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$28.4M |
| 4 |
CB
Cooke & Bieler
Philadelphia,
Pennsylvania
|
+$24.9M |
| 5 |
Millennium Management
New York
|
+$21.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$55M |
| 2 |
Brown Advisory
Baltimore,
Maryland
|
-$50.3M |
| 3 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$24.2M |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$19.4M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$13.8M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
301
Chevy Chase Trust
Bethesda,
Maryland
| – | -$21K | -352 | Closed |
|
|
FL
302
Fort LP
Chevy Chase,
Maryland
| – | -$20K | -348 | Closed |
|
|
NFG
303
Next Financial Group
Houston,
Texas
| – | -$15K | -251 | Closed |
|
|
CTC
304
Central Trust Company
Jefferson City,
Missouri
| – | -$13K | -220 | Closed |
|
|
IUHSA
305
Itau Unibanco Holding S.A.
Sao Paulo,
Brazil
| – | -$11K | -194 | Closed |
|
|
HGWM
306
Harvest Group Wealth Management
Waltham,
Massachusetts
| – | -$9.13K | -174 | -98% |
|
|
CT
307
Caldwell Trust
Venice,
Florida
| – | -$5.83K | -100 | Closed |
|
|
NL
308
NVWM LLC
Yardley,
Pennsylvania
| – | -$3K | -56 | Closed |
|
|
MF
309
Manchester Financial
Westlake Village,
California
| – | -$3K | -55 | Closed |
|
|
TWA
310
TCI Wealth Advisors
Tucson,
Arizona
| – | -$2K | -36 | Closed |
|
|
ASN
311
Advisory Services Network
Atlanta,
Georgia
| – | -$1K | -20 | Closed |
|
|
TFO
312
Tarbox Family Office
Newport Beach,
California
| – | -$1K | -20 | Closed |
|
|
OPS
313
Orion Portfolio Solutions
Omaha,
Nebraska
| – | -$367 | -7 | -41% |
|
|
GWS
314
Glassman Wealth Services
Vienna,
Virginia
| – | +$262 | +5 | New |
|
IART Hedge Fund Activity: Q1 2020 in Review
258 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q1 2020, worth a combined $3.2B — down 22% from $4.12B a quarter earlier.
Sellers outnumbered buyers: 58 funds closed out of IART and 39 opened new positions — a net loss of 19 holders — while 67 trimmed existing stakes and 115 added.
The largest buyer was Wells Fargo, adding an estimated $33.9M. The largest seller was Capital International Investors, cutting an estimated $55M.
- 258 institutional investors held Integra LifeSciences (IART) as of Q1 2020, down from 279 in Q4 2019.
- Funds reported $3.2B of Integra LifeSciences stock for Q1 2020, down 22% quarter-over-quarter.
- 39 funds opened new Integra LifeSciences positions in Q1 2020 and 58 closed out, a net change of -19 holders.
- The largest Integra LifeSciences buyer in Q1 2020 was Wells Fargo, an estimated $33.9M added.
- The largest Integra LifeSciences seller in Q1 2020 was Capital International Investors, an estimated $55M sold.
Based on aggregated 13F filings for Q1 2020.